BASILIXIMAB [SIMULECT®] DRAMATICALLY REDUCES ACUTE REJECTION AFTER PEDIATRIC KIDNEY TRANSPLANTATION.

• 1 April 2000
• journal article
• research article
• Published by Wolters Kluwer Health in Transplantation
• Vol. 69  (Supplement) , S260-S261
• https://doi.org/10.1097/00007890-200004271-00576

Abstract